Grant: Emerging Team Grant: Regenerative Medicine and Nanomedicine - LOI

Lung cancer is one of the leading cause of the death in world. With the current medical intervention, only 15% people survive 5 years after the initial diagnosis. There is also significant toxicity associated with current anticancer agents as normal tissues also killed along with cancer tissues during the treatment. Thus it is important to develop novel agents which can identify tumour sites and cure the cancer. In this project, we are developing a novel nanotechnology based new generation device for the delivery of anticancer drugs only to tumour sites and see them simultaneously. This novel nanodevice is based on a bio-degradable polymer developed recently in our laboratory. Drug loaded nanodevice will be attached with a specific agent that directly go to the tumour site when injected in the blood stream of human body without affecting other organs. This intelligent targeting in complex body environment will significantly reduce the side effects associated with the current anti-cancer treatments. This will be first the method to treat tumour growth as well see them receding in real time. This revolutionary next generation nanodevice platform will change current treatment methods, and will have broad applicability in treating many other cancers and other diseases.